Transcend Therapeutics - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Brookfield completes $3bn Oaktree buyout as credit platform reaches $365 bn

Williams to buy Momentum Midstream for $5.5bn as Haynesville LNG strategy accelerates

Snap revenue jumps 19% as AI advertising tools revive $SNAP investor confidence

Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test

Representative image: Neuropsychiatric drug research and brain imaging illustrate Otsuka Holdings’ Transcend Therapeutics acquisition and its push to advance TSND-201 as a potential next-generation PTSD treatment.

Read More

Pharma Industry News

Otsuka Holdings expands neuropsychiatry strategy with $1.23bn Transcend deal structure

Find out how Otsuka’s Transcend Therapeutics acquisition could reshape PTSD drug development and investor sentiment around TSE: 4578.

byPallavi Madhiraju

June 12, 2026

web analytics